gemfibrozil has been researched along with Hypolipoproteinemia in 14 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We conducted a double-blind trial comparing gemfibrozil (1200 mg per day) with placebo in 2531 men with coronary heart disease, an HDL cholesterol level of 40 mg per deciliter (1." | 9.09 | Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. ( Anderson, JW; Collins, D; Elam, MB; Faas, FH; Fye, CL; Linares, E; Robins, SJ; Rubins, HB; Schaefer, EJ; Schectman, G; Wilt, TJ; Wittes, J, 1999) |
| "We conducted a double-blind trial comparing gemfibrozil (1200 mg per day) with placebo in 2531 men with coronary heart disease, an HDL cholesterol level of 40 mg per deciliter (1." | 5.09 | Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. ( Anderson, JW; Collins, D; Elam, MB; Faas, FH; Fye, CL; Linares, E; Robins, SJ; Rubins, HB; Schaefer, EJ; Schectman, G; Wilt, TJ; Wittes, J, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (21.43) | 18.7374 |
| 1990's | 7 (50.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| King, JM | 1 |
| Crouse, JR | 1 |
| Terry, JG | 1 |
| Morgan, TM | 1 |
| Spray, BJ | 1 |
| Miller, NE | 1 |
| Vega, GL | 2 |
| Grundy, SM | 2 |
| Simo, IE | 1 |
| Yakichuk, JA | 1 |
| Ooi, TC | 1 |
| Cimminiello, C | 1 |
| Vigorelli, P | 1 |
| Piliego, T | 1 |
| Soncini, M | 1 |
| Toschi, V | 1 |
| Arpaia, G | 1 |
| Perolini, S | 1 |
| Bonfardeci, C | 1 |
| Rubins, HB | 2 |
| Robins, SJ | 3 |
| Collins, D | 1 |
| Fye, CL | 1 |
| Anderson, JW | 1 |
| Elam, MB | 1 |
| Faas, FH | 1 |
| Linares, E | 1 |
| Schaefer, EJ | 2 |
| Schectman, G | 1 |
| Wilt, TJ | 1 |
| Wittes, J | 1 |
| Zema, MJ | 1 |
| Noto, H | 1 |
| Kinoshita, M | 1 |
| Kashyap, ML | 1 |
| Saku, K | 1 |
| Hunninghake, DB | 1 |
| Glueck, CJ | 1 |
| Melser, MA | 1 |
| Borecki, IB | 1 |
| Third, JL | 1 |
| Rao, DC | 1 |
| Laskarzewski, PM | 1 |
| Levy, RI | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Low Carbohydrate Diet Compared to Low Fat Diet in Reversing the Metabolic Syndrome Using NCEP ATP III Criteria; Randomized Clinical Trial[NCT04681924] | 94 participants (Actual) | Interventional | 2017-01-01 | Completed | |||
| CSP #363 - The VA HDL Intervention Trial (HIT): Secondary Prevention of Coronary Heart Disease in Men With Low HDL-Cholesterol and Desirable LDL-Cholesterol[NCT00283335] | Phase 3 | 2,531 participants (Actual) | Interventional | 1991-06-30 | Completed | ||
| Treatment Study for Severe High-Density Lipoprotein Deficiency[NCT00458055] | 19 participants (Actual) | Interventional | 2006-11-30 | Completed | |||
| Estudio clínico Fase III Para Evaluar la Eficacia terapéutica en Pacientes Mexicanos Con Dislipidemia Mediante el Uso vía Oral de L-Carnitina + Atorvastatina Comparado Con Atorvastatina[NCT03696940] | Phase 3 | 120 participants (Actual) | Interventional | 2018-05-28 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for gemfibrozil and Hypolipoproteinemia
| Article | Year |
|---|---|
[VA-HIT Study [Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study]].
Topics: Aged; Cholesterol, HDL; Coronary Disease; Gemfibrozil; Humans; Hypolipidemic Agents; Hypolipoprotein | 2001 |
Targeting low high-density lipoprotein cholesterol for therapy: lessons from the Veterans Affairs High-density Lipoprotein Intervention Trial.
Topics: Cholesterol, HDL; Coronary Disease; Gemfibrozil; Humans; Hypolipidemic Agents; Hypolipoproteinemias; | 2001 |
Drug treatment of dyslipoproteinemia.
Topics: Bile Acids and Salts; Clofibrate; Coronary Disease; Drug Therapy, Combination; Gemfibrozil; Humans; | 1990 |
Familial hypoalphalipoproteinemia.
Topics: Cholesterol, HDL; Diet, Reducing; Exercise Therapy; Gemfibrozil; Humans; Hypolipoproteinemias; Pedig | 1986 |
Pathogenesis and management of lipoprotein disorders.
Topics: Abetalipoproteinemia; Adolescent; Adult; Aged; Child; Child, Preschool; Cholestyramine Resin; Chylom | 1985 |
5 trials available for gemfibrozil and Hypolipoproteinemia
4 other studies available for gemfibrozil and Hypolipoproteinemia
| Article | Year |
|---|---|
Lipoprotein responses to treatment with lovastatin, gemfibrozil, and nicotinic acid in normolipidemic patients with hypoalphalipoproteinemia.
Topics: Gemfibrozil; Humans; Hypolipoproteinemias; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lovas | 1994 |
Fibrinolytic response in subjects with hypertriglyceridemia and low HDL cholesterol.
Topics: Aged; Analysis of Variance; Cholesterol, HDL; Female; Fibrinolysis; Gemfibrozil; Humans; Hypertrigly | 1997 |
Conclusions from the VA-HIT study.
Topics: Cholesterol, HDL; Coronary Disease; Gemfibrozil; Humans; Hypolipidemic Agents; Hypolipoproteinemias; | 2000 |
HDL metabolism in HDL deficiency associated with familial hypertriglyceridemia: effect of treatment with gemfibrozil.
Topics: Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins A; Drug Therapy, Combination; Gemfibrozil; | 1991 |